- Home
- SNEX vs LNTH Comparison
SNEX vs LNTH Comparison
Compare SNEX & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNEX | LNTH |
|---|---|---|
| Founded | 1924 | 1956 |
| Country | United States | United States |
| Employees | 5400 | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.9B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SNEX | LNTH |
|---|---|---|
| Price | $108.28 | $72.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $122.00 | $83.20 |
| AVG Volume (30 Days) | 372.6K | ★ 863.6K |
| Earning Date | 05-06-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.50 | ★ 3.41 |
| Revenue | ★ $132,378,200,000.00 | $343,374,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.69 | $13.47 |
| P/E Ratio | $47.81 | ★ $22.28 |
| Revenue Growth | ★ 32.53 | 3.62 |
| 52 Week Low | $65.58 | $47.27 |
| 52 Week High | $132.57 | $111.29 |
Technical Indicators
Market Signals| Indicator | SNEX | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 36.17 | 52.23 |
| Support Level | $92.71 | $69.12 |
| Resistance Level | $130.35 | $73.72 |
| Average True Range (ATR) | 4.95 | 2.97 |
| MACD | -2.45 | 0.02 |
| Stochastic Oscillator | 0.08 | 29.18 |
Price Performance
Historical ComparisonAbout SNEX StoneX Group Inc.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.